期刊文献+

卵泡抑素样蛋白1与宫颈癌高危型HPV感染关联性研究 被引量:7

Correlation between follistatin-like protein 1 and high-risk HPV infection in cervical cancer
原文传递
导出
摘要 目的卵泡抑素样蛋白l(follistatin-like protein 1,FSTL1)是一种分泌性糖蛋白,在人类多种肿瘤中出现异常表达。本研究旨在探讨FSTL1在宫颈癌中的表达情况及与宫颈癌高危型人乳头状瘤病毒(high-risk human papilloma virus, HR-HPV)感染的关系。方法收集2015-04-13-2017-05-24广西壮族自治区人民医院妇科66例宫颈癌组织样本和 21 例正常宫颈组织样本。采用实时荧光定量 PCR (fluorogenic quantitative reverse transcriptase polymerase chainreaction, RT-qPCR)检测样本中 FSTL1 mRNA 的表达量,巢式多重 PCR (nested multiplex polymerase chain reaction,NMPCR)检测66例宫颈癌组织样本中HPV-16、18、31、45、52和58分型,分析FSTL1 mRNA的表达量与HPV感染的关系;将宫颈癌HeLa细胞株分为实验组、阴性对照组和空白对照组,实验组转染HPV-18E6/E7小干扰RNA(smallRNA interference, siRNA),阴性对照组转染阴性对照siRNA,空白对照组不做处理,每组设置3个复孔,RT-qPCR技术检测HPV-18E6/E7 siRNA转染前后宫颈癌HeLa细胞株中FSTL1 mRNA的表达情况。结果 FSTL1 mRNA在66例宫颈癌组织样本中相对表达量的中位数(极差)为0. 059(0.004,0. 789),在21例正常宫颈组织相对表达量的中位数(极差)为1. 051(0. 517,1. 539),差异有统计学意义,Z= 6. 765,PV0. 001;FSTLl mRNA在HPV感染阳性组中相对表达量的中位数(极差)为0. 057(0. 004,0. 698),在HPV感染阴性组中相对表达量的中位数(极差)为0. 226(0. 030,0. 789),差异有统计学意义,Z= 3. 071,P<0. 001;FSTL1 mRNA高表达组(27. 27%)的HPV感染率低于低表达组(93. 94%),差异有统计学意义,才=5. 345, P = 0. 021;HeLa 细胞转染 HPV-18E6 siRNA 后,HPV-18E6 mRNA(0. 269 + 0. 037,F=79. 946, PV0. 001)的相对表达量下调,FSTL1 mRNA的相对表达量为2. 922 士 0. 239,较阴性对照组(0. 978 + 0. 076)及空白对照组(1. 000 + 0. 029)上调,差异有统计学意义,F= 175. 347, P<0. 001;HeLa细胞转染HPV-18E7 siRNA 后,HPV- 18E7 mRNA(0. 335± 0. 040, F= 50. 442, PV0. 001)表达量下调,FSTL1 mRNA 的相对表达量为3.798 + 0. 059,较阴性对照组(0. 906土0. 058)及空白对照组(1. 001 士0. 060)上调,差异有统计学意义,F=2 330. 835,P<0. 001。结论 FSTL1 mRNA在宫颈癌组织中低表达,FSTL1 mRNA的表达量与宫颈癌HPV感染有关。 OBJECTIVE Follistatin-like protein 1 ( FSTL1) is a secretory glycoprotein, which is abnormally expressed in a variety of human tumors. The recent research on FSTL1 in cervical cancer has rarely been reported. This study aimed to investigate the expression FSTL1 in cervical cancer and and its relationship with high-risk human papillomavirus. METHODS The expression of FSTL1 mRNA of 66 cases of cervical cancer tissues and 21 cases of normal cervical cancer tissue samples collected from the Department of Gynecology Guangxi Zhuang Autonomous Region People’s Hospital from 2015-04-13 - 2017-05-24, was detected and analyzed by fluorogenic quantitative reverse transcriptase polymerase chain reaction(RT-qPCR). The nested multiplex polymerase chain reaction(NMPCR) was used to detect and analyze the classification of HPV-16,18,31,45,52,58 in the above 66 cervical cancer tissues samples. Analysis of the relationship between the expression of FSTL1 mRNA and HPV infection. The cervical cancer HeLa cell line was divided into experimental group,negative control group and blank control group. The experimental group was transfected with HPV-18E6/E7 small RNA interference(siRNA),the negative control group was transfected with negative control siRNA,the blank control group was not treated,and each group was set with 3 duplicate wells. RT-qPCR was used to detect the expression of FSTL1 mRNA in cervical cancer HeLa cell line before and after HPV-18E6/E7 siRNA transfection. RESULTS The median( range) relative expression of FSTL1 mRNA in 66 cervical cancer tissues was 0. 059(0. 004,0. 789),and the median (range) relative expression in 21 normal cervical tissues was 1. 051(0. 517,1. 539),the difference was statistically significant( Z=-6. 765,PV0. 001). The median(range) relative expression of FSTL1 mRNA in the HPV-positive group was 0. 057(0. 004,0. 698),and the median(range) relative expression in the HPV-infected group was 0. 226(0.030,0.789), the difference was statistically significant(Z=- 3. 071, P<C0. 001). The HPV infection rate in the high expression group of FSTL1 mRNA (27. 27%) was lower than that in the low expression group (93. 94%),and the difference was statistically significant(x^2=5. 345 , P = 0. 021). After HeLa cells were transfected with HPV-18E6 siRNA, the expression level of HPV-18E6 mRNA(0. 269土0. 037 ,F= 79. 946 ,PV0. 001) was down-regulated. The relative expression of FSTL1 mRNA was (2. 922±0. 239) higher than that of the negative control group (0. 978 zt 0. 076) and the blank control group (1. 000±0. 029). The difference was statistically significant(F- 175. 347,PV0. 001). After HeLa cells were transfected with HPV-18E7 siRNA,the expression level of HPV-18E7 mRNA (0. 335dz0. 040, F= 50. 442, PV0. 001) was downregulated. The relative expression of FSTL1 mRNA was 3. 798 + 0. 059, which was higher than that of the negative control group (0. 906 ±0. 058) and the blank control group (1. 001 ±0. 060). The difference was statistically significant (F = 2 330. 835,PV0. 001). CONCLUSION The expression of FSTLlmRNA is down-regulated in cervical cancer tissues and it is related to HPV infection in cervical cancer.
作者 张红 胡晓霞 洛若愚 刘珍 李梦如 杨琅 ZHANG Hong;HU Xiao-jcia;LUO Ruo-yu;LIU Zhen;LI Meng-ru;YANG Lang(Department of Gynaecology ,Renmin Hospital of Wuhan University .Wuhan 430000,P. R. China;Department of Gynaecology , Peopief s Hospital of Guangxi Zhuang Autonomous Region , Nanning 530021, P. R. China)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2019年第10期675-681,共7页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(81660434)
关键词 宫颈癌 卵泡抑素样蛋白1 高危型HPV 小干扰RNA 关联性 cervical cancer follistatin-like protein 1 high-risk HPV small interfering RNA correlation
  • 相关文献

参考文献6

二级参考文献48

  • 1刘欣,刘国炳,庞战军,邢福祺,郭遂群,马文丽,郑文岭.PCR直接测序法检测宫颈癌组织中人乳头瘤病毒DNA[J].第一军医大学学报,2005,25(2):201-203. 被引量:8
  • 2鲍彦平,李霓,王鹤,乔友林.中国妇女子宫颈人乳头瘤病毒型别分布的Meta分析[J].中华流行病学杂志,2007,28(10):941-946. 被引量:79
  • 3Scaria V, Hariharan M, Brahmachari SK, et al. MicroRNA: an emerging therapeutie[J]. Chem Med Chem, 2007, 2 (6) : 789- 792.
  • 4Yuan C, et al. High-risk human papillomavirusreduces the expression of microRNA 218 in women with cervical intraepithelial neoplasia[J]. J Int Med Res, 2010,38(5) : 1730- 1736.
  • 5Jung HM, Phillips BL, Chan EK. MiR-375 activates p21 and suppresses telomerase activity by coordinately regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3zeta[J]. Mol Cancer,2014, 13:80.
  • 6Tang S, Tao M, Mccoy JJ, et al. The E7 oncoprotein is translated from spliced E6 I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell fines via translation reinitiation[J]. Virol, 2006,80 (9) : 4249- 4263.
  • 7Liu W, Gao G, Hu X, et al. Activation of miR-9 by human papillomavirus in cervical cancer [ J 1. Oncotarget, 2014,5 ( 22 ), 11620-11630.
  • 8Yamamoto N, Kinoshita T, Nohata N, et al. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamouscell carcinoma[J]. Int J Oncol, 2013,42(5):1523- 1532.
  • 9Yao T, Lin Z. MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20[J]. Biochim Biophys Acta, 2012,1822(2) : 248-260.
  • 10Duensing S, Lee LY, Duensing A, et al. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomie instability by uncoupling centrosome duplication {tom the cell division cycle[J]. Proe Nail Acad Sci USA,2000,97(18) : 10002-10007.

共引文献167

同被引文献57

引证文献7

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部